Alvotech (ALVO) Payables (2020 - 2026)
Alvotech (ALVO) posted Payables of $119.6 million for Q1 2026, down 33.58% on a QoQ basis from $180.1 million in Q4 2025, and down 56.99% year-over-year from $278.1 million in Q1 2025.
Alvotech (ALVO) Payables (2020 - 2026) Analysis & Trends
Alvotech's Payables history runs 7 years deep, the most recent figure standing at $119.6 million for Q1 2026.
- Quarterly Payables fell 56.99% year-over-year to $119.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $119.6 million (down 56.99% YoY) and the FY2025 annual result came in at $180.1 million, down 35.06% from the prior year.
- Payables was $119.6 million for Q1 2026 at Alvotech, down from $180.1 million in the prior quarter.
- Across five years, Payables topped out at $601.1 million in Q4 2023 and bottomed at $119.6 million in Q1 2026.
- A 5-year average of $305.8 million and a median of $275.2 million in 2023 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables jumped 1402.15% — and 2026, when it tumbled 56.99%.
- Alvotech's Payables stood at $429.4 million in 2022, then surged by 39.98% to $601.1 million in 2023, then sank by 53.86% to $277.3 million in 2024, then sank by 35.06% to $180.1 million in 2025, then tumbled by 33.58% to $119.6 million in 2026.
- Business Quant data shows ALVO's Payables at $119.6 million in Q1 2026, $180.1 million in Q4 2025, and $301.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 731.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 8.82 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | 119.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119.63 Mn |
| Dec 31, 2025 | 180.12 Mn |
| Sep 30, 2025 | 301.85 Mn |
| Jun 30, 2025 | 147.29 Mn |
| Mar 31, 2025 | 278.11 Mn |
| Dec 31, 2024 | 277.35 Mn |
| Sep 30, 2024 | 240.08 Mn |
| Jun 30, 2024 | 260.24 Mn |
| Mar 31, 2024 | 381.15 Mn |
| Dec 31, 2023 | 601.12 Mn |
| Jun 30, 2023 | 272.98 Mn |
| Mar 31, 2023 | 550.34 Mn |
| Dec 31, 2022 | 429.42 Mn |
| Jun 30, 2022 | 242.20 Mn |
| Dec 31, 2021 | 28.59 Mn |
| Dec 31, 2020 | 546.65 Mn |